Form D — Simbryo Technologies, Inc.
0002147331-26-000001 · filed Jul 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,252,615
- Reported amount sold
- $5,250,972
- Minimum investment
- $0
- Investors
- 24
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Simbryo Technologies, Inc.
- CIK
- 2147331
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 4430 OSBY DR.
HOUSTON, TX 77096 - Phone
- 512-763-2196
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Yael Katz · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Aryeh Warmflash · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Stephen Rooks · DirectorHouston, TX Find on LinkedIn ↗
-
Andrea Mazzocchi · DirectorHouston, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗